[…]
TH07 Clinical Study Featured in Peer-Reviewed Scientific Journal

[…]
[…]
[…]
[…]
[…]
Dieppe, NB, Canada, April 16, 2020 – Triple Hair Inc. (“Triple Hair”) is pleased to announce that it has retained Endoceutics Pharma MSH Inc. (“Endoceutics”), a world-renowned Contract Manufacturing Organization (“CMO”), to support Triple Hair’s new patented TH07 hair growth product through clinical trials and eventual commercialization. […]